One in every eight patients admitted to an acute psychiatric unit had been using the synthetic cannabis K2, an audit published today has found.
Researchers from Dunedin Hospital and Otago University checked records at an acute ward in the city from January 1 to mid-April and found 13 per cent of patients had said they were using K2.
The researchers say in today's NZ Medical Journal that their findings suggest synthetic cannabis can trigger psychosis both in those with no history of the mental disorder and in those who have had previous episodes.
"We also identified high rates of suicidal thinking and one instance of homicidal ideation [thinking about killing someone else] in this case series."
The patients' other symptoms included paranoia, disordered thinking, disorganised behaviour, anxiety and depression.